Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Andrx replaces CEO

Executive Summary

Former Chesapeake Biological Labs CEO Thomas Rice replaces Richard Lane as Andrx' chief executive. Rice, who joined Andrx' board in April, says the change was "in no way associated with the company's finances, accounting or business conditions," but was aimed at accelerating implementation of strategic initiatives. Lane joined Andrx in June 2002 after leaving Bristol-Myers Squibb as part of a management change following disclosure of inventory problems (1"The Pink Sheet" May 27, 2002, p. 21)...

You may also be interested in...

Andrx Reviewing Brand Strategy Ahead Of Fortamet Launch

Andrx will launch diabetes agent Fortamet (metformin extended-release) as it is reducing emphasis on branded product development and marketing

Andrx Puts Branded Rx Line In Fast Lane: Ex-Bristol Exec Joins As CEO

Andrx CEO Richard Lane will oversee the launch of the extended-release lovastatin formulation Altocor

Rare Disease Advocates Lobby US Congress For FDA Center of Excellence

Number one ask is for congressional pressure to centralize rare disease expertise at the agency, but advocates also are preparing legislation that would mandate the new center.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts